NDC11 69794034609
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 69794-0346-09 | 69794-0346 |
| 69794-0346-9 | 69794-0346 |
| 69794-346-09 | 69794-346 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FAYUVI | REBISUFLIGENE ETISPARVOVEC-HOPF | Ultragenyx Pharmaceutical Inc. | 996fc33a-26d3-4fae-bd0c-a2edd7764539 | 2026-10-01 | Warnings, Adverse reactions | 69794-346-09 69794-346 69794034609 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.